Cart
Shopping cart

Ildikó Dr. Molnár

Zinzino Independent Partner

Sveiki, esu nepriklausomas konsultantas(-ė) ir ketinu jums padėti Jūsų kelionėje link geresnės sveikatos.

Okidli101@gmail.com
Kopijuoti
Press releases - 2025 m. vasario 5 d., trečiadienis 10:00 CET

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2025

Zinzino group revenue increased with a total of 57 %, compared with the previous year.

The revenue in January for Zinzino's sales markets increased by 62% and amounted to SEK 228.7 (140.9) million. Faun Pharma's external sales decreased and amounted to SEK 4.7 (8.1) million. Overall, the Group increased revenues by 57% to SEK 233.4 (149.0) million compared with the previous year.

Revenues were distributed as follows:

Regions, mSEK 25-Jan 24-Jan Change
The Nordics 25.5 22.8 12%
Central Europe 69.5 40.9 70%
East Europe 34.2 31.8 8%
South & West Europe 44.6 22.0 101%
The Baltics 10.3 8.0 29%
North America 22.2 10.4 113%
Asia-Pacific 20.8 4.0 420%
Africa 1.6 1.0 60%
Zinzino 228.7 140.9 62%
Faun Pharma 4.7 8.1 -42%
Zinzino Group 233.4 149.0 57%

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

 

For more information: 
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, www.zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ.)